FDA approves first therapy to treat patients with rare blood disorder

News, stream
FDA grants approval to Reblozyl (luspatercept–aamt) for the treatment of anemia in adult patients with beta thalassemia who require regular red-blood cell transfusions.

Follow MrTopStep in our Social Space:

Tradechat (1417 Posts)


Leave a Reply